Skip to main content


Page 5 of 20

  1. To investigate the role of preoperative body composition analysis for muscle and adipose tissue distribution on long-term oncological outcomes in patients with middle and low rectal cancer (RC) who received cu...

    Authors: Jiyang Liu, Xiongfeng Yu, Xueqing Huang, Qingquan Lai and Jieyun Chen
    Citation: Cancer Imaging 2023 23:5
  2. PET/MRI is an emerging imaging modality which enables the evaluation and quantification of biochemical processes in tissues, complemented with accurate anatomical information and low radiation exposure. In the...

    Authors: Stefan Prado-Wohlwend, Mónica Ballesta-Moratalla, Irene Torres-Espallardo, María Isabel del Olmo-García, Pilar Bello-Arques, Consuelo Olivas-Arroyo and Juan Francisco Merino-Torres
    Citation: Cancer Imaging 2023 23:4
  3. Early diagnosis of prostate cancer improves its prognosis, while it is essential to upgrade screening tools. This study aimed to explore the value of a novel functional magnetic resonance imaging (MRI) techniq...

    Authors: Lu Yang, Lei Wang, Yuchuan Tan, Hanli Dan, Peng Xian, Yipeng Zhang, Yong Tan, Meng Lin and Jiuquan Zhang
    Citation: Cancer Imaging 2023 23:3
  4. The aim of this study is to investigate the impact of 18F-FDG PET/CT on prognosis of stage II invasive ductal carcinoma (IDC) of the breast primarily treated with surgery.

    Authors: Hye Lim Park, Sea-Won Lee, Ji Hyung Hong, Jieun Lee, Ahwon Lee, Soo Jin Kwon, Sonya Youngju Park and Ie Ryung Yoo
    Citation: Cancer Imaging 2023 23:2
  5. A comparative retrospective study to assess the impact of PSMA Ligand PET/MRI ([68 Ga]-Ga-PSMA-11 and [18F]-F-PSMA-1007 PET/MRI) as a new method of target delineation compared to conventional imaging on whole-...

    Authors: Lin-Lin Liu, Lei-Lei Zhu, Zhen-Guo Lu, Jun-Die Sun, Jun Zhao, Hai-Feng Wang and Zuo-Lin Xiang
    Citation: Cancer Imaging 2023 23:1
  6. The injection activity of tracer, acquisition time, patient-specific photon attenuation, and large body mass, can influence on image quality. Fixed acquisition time and body mass related injection activity in ...

    Authors: Jie Xiao, Haojun Yu, Xiuli Sui, Guobing Liu, Yanyan Cao, Zhao Yanzhao, Yiqiu Zhang, Pengcheng Hu, Dengfeng Cheng and Hongcheng Shi
    Citation: Cancer Imaging 2022 22:78
  7. To evaluate the performance of diffusion-relaxation correlation spectrum imaging (DR-CSI) with support vector machine (SVM) in detecting prostate cancer (PCa).

    Authors: Xiaobin Wei, Li Zhu, Yanyan Zeng, Ke Xue, Yongming Dai, Jianrong Xu, Guiqin Liu, Fang Liu, Wei Xue, Dongmei Wu and Guangyu Wu
    Citation: Cancer Imaging 2022 22:77
  8. To find semi-quantitative and quantitative Positron Emission Tomography/Magnetic Resonance (PET/MR) imaging metrics of both tumor and non-malignant lymphoid tissue (bone marrow and spleen) for Progression Free...

    Authors: Therese Sjöholm, Alexander Korenyushkin, Gustav Gammelgård, Tina Sarén, Tanja Lövgren, Angelica Loskog, Magnus Essand, Joel Kullberg, Gunilla Enblad and Håkan Ahlström
    Citation: Cancer Imaging 2022 22:76

    The Correction to this article has been published in Cancer Imaging 2023 23:46

  9. Texture analysis derived from computed tomography (CT) can provide clinically relevant imaging biomarkers. Node-RADS is a recently proposed classification to categorize lymph nodes in radiological images. The ...

    Authors: Hans-Jonas Meyer, Benedikt Schnarkowski, Johanna Pappisch, Teresa Kerkhoff, Hubert Wirtz, Anne-Kathrin Höhn, Sebastian Krämer, Timm Denecke, Jakob Leonhardi and Armin Frille
    Citation: Cancer Imaging 2022 22:75
  10. To construct a model based on magnetic resonance imaging (MRI) features and histological and clinical variables for the prediction of pathology-detected extracapsular extension (pECE) in patients with prostate...

    Authors: Adalgisa Guerra, Filipe Caseiro Alves, Kris Maes, Steven Joniau, João Cassis, Rui Maio, Marília Cravo and Helena Mouriño
    Citation: Cancer Imaging 2022 22:74

    The Correction to this article has been published in Cancer Imaging 2023 23:32

  11. Response assessment in the context of immunomodulatory treatments represents a major challenge for the medical imaging community and requires a multidisciplinary approach with involvement of oncologists, radio...

    Authors: E. Lopci, N. Aide, A. Dimitrakopoulou-Strauss, L. Dercle, A. Iravani, R. D. Seban, C. Sachpekidis, O. Humbert, O. Gheysens, A. W. J. M. Glaudemans, W. A. Weber, A. D. Van den Abbeele, R. L. Wahl, A. M. Scott, N. Pandit-Taskar and R. J. Hicks
    Citation: Cancer Imaging 2022 22:73
  12. High-risk differentiated thyroid cancer (DTC) needs effective early prediction tools to improving clinical management and prognosis. This cohort study aimed to investigate the prognostic impact of 99mTc-PEG4-E[PE...

    Authors: Yiqian Liang, Xi Jia, Yuanbo Wang, Yan Liu, Xiaobao Yao, Yanxia Bai, Peng Han, Si Chen, Aimin Yang and Rui Gao
    Citation: Cancer Imaging 2022 22:72
  13. Biologically targeted radiation therapy treatment planning requires voxel-wise characterisation of tumours. Dynamic contrast enhanced (DCE) DCE MRI has shown promise in defining voxel-level biological characte...

    Authors: Hayley M. Reynolds, Sirisha Tadimalla, Yu-Feng Wang, Maryam Montazerolghaem, Yu Sun, Scott Williams, Catherine Mitchell, Mary E. Finnegan, Declan G. Murphy and Annette Haworth
    Citation: Cancer Imaging 2022 22:71
  14. This review describes the main benefits of using long axial field of view (LAFOV) PET in clinical applications. As LAFOV PET is the latest development in PET instrumentation, many studies are ongoing that expl...

    Authors: Joyce van Sluis, Ronald Borra, Charalampos Tsoumpas, Johannes H. van Snick, Mostafa Roya, Dik ten Hove, Adrienne H. Brouwers, Adriaan A. Lammertsma, Walter Noordzij, Rudi A.J.O. Dierckx, Riemer H.J.A. Slart and Andor W.J.M. Glaudemans
    Citation: Cancer Imaging 2022 22:69
  15. Magnetic resonance imaging (MRI) can be used to diagnose breast cancer. Diffusion weighted imaging (DWI) and the apparent diffusion coefficient (ADC) can reflect tumor microstructure in a non-invasive manner. ...

    Authors: Alexey Surov, Maciej Pech, Hans-Jonas Meyer, Almir G. V. Bitencourt, Hiroshi Fujimoto, Gabrielle C. Baxter, Gorane Santamaría, Fiona J. Gilbert and Andreas Wienke
    Citation: Cancer Imaging 2022 22:68
  16. Nodal size is an important imaging criterion for differentiating benign from malignant nodes in the head and neck cancer staging. This study evaluated the size of normal nodes in less well-documented nodal gro...

    Authors: Qi Yong H. Ai, Tiffany Y. So, Kuo Feng Hung and Ann D. King
    Citation: Cancer Imaging 2022 22:66
  17. To observe the diagnostic efficacy of preoperative fluorine-18 fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) upon venous tumor thrombus (VTT) in patients with renal cell c...

    Authors: Silu Chen, Yanyan Zhao, Qi Tang, Caixia Wu, Aixiang Wang, Linlin Ma, Xi Zhang, Jinzhi Chen, Yuan Gao, Xuhe Liao, Ninghan Feng, Yan Fan, Jianhua Zhang, Xuesong Li and Meng Liu
    Citation: Cancer Imaging 2022 22:65
  18. Parathyroid carcinoma (PC) and atypical parathyroid tumor (APT) are rare parathyroid disorders carrying the risk of recurrence of varying degrees. This study aims to explore the value of 2D-shear wave elastogr...

    Authors: Ruifeng Liu, Luying Gao, Xinlong Shi, Liyuan Ma, Ou Wang, Weibo Xia, Ya Hu, Yu Xia and Yuxin Jiang
    Citation: Cancer Imaging 2022 22:64
  19. Advances in molecular diagnostics accomplished the discovery of two malignant glioma entities harboring alterations in the H3 histone: diffuse midline glioma, H3 K27-altered and diffuse hemispheric glioma, H3 ...

    Authors: Arian Lasocki, Gehad Abdalla, Geoffrey Chow and Stefanie C. Thust
    Citation: Cancer Imaging 2022 22:63
  20. Esophageal fistula is one of the most serious complications of chemotherapy or chemoradiotherapy (CRT) for advanced esophageal cancer. This study aimed to evaluate the performance of quantitative computed tomo...

    Authors: Yan-Jie Shi, Chang Liu, Yi-Yuan Wei, Xiao-Ting Li, Lin Shen, Zhi-Hao Lu and Ying-Shi Sun
    Citation: Cancer Imaging 2022 22:62
  21. Lymphovascular invasion (LVI) predicts a poor outcome of breast cancer (BC), but LVI can only be postoperatively diagnosed by histopathology. We aimed to determine whether quantitative parameters of dynamic co...

    Authors: Tianfu Lai, Xiaofeng Chen, Zhiqi Yang, Ruibin Huang, Yuting Liao, Xiangguang Chen and Zhuozhi Dai
    Citation: Cancer Imaging 2022 22:61
  22. Survivors of testicular cancer may experience long-term morbidity following treatment. There is an unmet need to investigate techniques that can differentiate individuals who need additional therapy from those...

    Authors: Ciara Conduit, Thuan Tzen Koh, Michael S Hofman, Guy C Toner, Jeremy Goad, Nathan Lawrentschuk, Keen-Hun Tai, Jeremy H Lewin and Ben Tran
    Citation: Cancer Imaging 2022 22:58
  23. Breast cancer screening is essential in detecting breast tumors, however, the examination is stressful. In this study we analyzed whether humor enhances patient satisfaction.

    Authors: Elisabeth Sartoretti, Thomas Sartoretti, Dow Mu Koh, Sabine Sartoretti-Schefer, Sebastian Kos, Romana Goette, Ricardo Donners, Robyn Benz, Johannes M. Froehlich, Simon Matoori, Peter Dubsky, Tino Plümecke, Rosemarie Forstner, Willibald Ruch, Matthias Meissnitzer, Klaus Hergan…
    Citation: Cancer Imaging 2022 22:57
  24. This study aimed to evaluate the diagnostic capacity of apparent diffusion coefficient (ADC) in predicting pathological Masaoka and T stages in patients with thymic epithelial tumors (TETs).

    Authors: Chao-Chun Chang, Chia-Ying Lin, Li-Ting Huang, Ming-Tsung Chuang, Ying-Hung Lu, Wei-Li Huang, Ying-Yuan Chen, Wu-Wei Lai, Yau-Lin Tseng and Yi-Ting Yen
    Citation: Cancer Imaging 2022 22:56
  25. To compare the diagnostic performance of international hepatocellular carcinoma (HCC) guidelines with gadoxetic acid-enhanced MRI (EOB-MRI) and contrast-enhanced Computed tomography (CECT) and their impact on ...

    Authors: Devang Odedra, Ali Babaei Jandaghi, Rajesh Bhayana, Khaled Y. Elbanna, Osvaldo Espin-Garcia, Sandra E. Fischer, Anand Ghanekar, Gonzalo Sapisochin and Kartik S. Jhaveri
    Citation: Cancer Imaging 2022 22:55
  26. Early tumor shrinkage (ETS) has been identified as a promising imaging biomarker for patients undergoing immunotherapy for several cancer entities. This study aimed to validate the potential of ETS as an imagi...

    Authors: Lukas Müller, Simon Johannes Gairing, Roman Kloeckner, Friedrich Foerster, Eva Maria Schleicher, Arndt Weinmann, Jens Mittler, Fabian Stoehr, Moritz Christian Halfmann, Christoph Düber, Peter Robert Galle and Felix Hahn
    Citation: Cancer Imaging 2022 22:54
  27. To compare [68Ga]PSMA-11 PET-CT, [68Ga]PSMA-11 PET-MRI and MRI in a cohort of prostate cancer (PCa) patients in biochemical recurrence after initial curative therapy.

    Authors: P. A. Glemser, L. T. Rotkopf, C. H. Ziener, B. Beuthien-Baumann, V. Weru, A. Kopp-Schneider, H. P. Schlemmer, A. Dimitrakopoulou-Strauss and C. Sachpekidis
    Citation: Cancer Imaging 2022 22:53
  28. In nasal or sinonasal tumors, orbital invasion beyond periorbita by the tumor is one of the important criteria in the selection of the surgical procedure. We investigated the usefulness of the convolutional ne...

    Authors: Junichi Nakagawa, Noriyuki Fujima, Kenji Hirata, Minghui Tang, Satonori Tsuneta, Jun Suzuki, Taisuke Harada, Yohei Ikebe, Akihiro Homma, Satoshi Kano, Kazuyuki Minowa and Kohsuke Kudo
    Citation: Cancer Imaging 2022 22:52
  29. To develop a radiomics model based on pretreatment whole-liver portal venous phase (PVP) contrast-enhanced CT (CE-CT) images for predicting metachronous liver metastases (MLM) within 24 months after rectal can...

    Authors: Meng Liang, Xiaohong Ma, Leyao Wang, Dengfeng Li, Sicong Wang, Hongmei Zhang and Xinming Zhao
    Citation: Cancer Imaging 2022 22:50
  30. Molecular imaging technologies are increasingly used to diagnose, monitor, and guide treatment of i.e., cancer. In this review, the current status and future prospects of the use of molecular imaging as an in...

    Authors: Imke Boekestijn, Matthias N. van Oosterom, Paolo Dell’Oglio, Floris H. P. van Velden, Martin Pool, Tobias Maurer, Daphne D. D. Rietbergen, Tessa Buckle and Fijs W. B. van Leeuwen
    Citation: Cancer Imaging 2022 22:48
  31. To combine intravoxel incoherent motion (IVIM) imaging and diffusion kurtosis imaging (DKI) parameters for the evaluation of radiotherapy response in rabbit VX2 malignant bone tumor model.

    Authors: Jia Guo, Weikai Sun, Cheng Dong, Zengjie Wu, Xiaoli Li, Ruizhi Zhou and Wenjian Xu
    Citation: Cancer Imaging 2022 22:47
  32. To establish a nomogram for predicting the risk of adenocarcinomas in patients with subsolid nodules (SSNs) according to the 2021 WHO classification.

    Authors: Qilong Song, Biao Song, Xiaohu Li, Bin Wang, Yuan Li, Wu Chen, Zhaohua Wang, Xu Wang, Yongqiang Yu, Xuhong Min and Dongchun Ma
    Citation: Cancer Imaging 2022 22:46
  33. We aimed to evaluate the prevalence of incidental 68 Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET/CT (SSTR PET/CT) findings, their clinical significance in the need for follow-up, and their risk...

    Authors: Morten Bentestuen, Farid Gossili, Charlotte Elberling Almasi and Helle Damgaard Zacho
    Citation: Cancer Imaging 2022 22:44
  34. High early recurrence (ER) of hepatocellular carcinoma (HCC) after microwave ablation (MWA) represents a sign of aggressive behavior and severely worsens prognosis. The aim of this study was to estimate the ou...

    Authors: Zhaohe Zhang, Jie Yu, Sisi Liu, Linan Dong, Tiefang Liu, Haiyi Wang, Zhiyu Han, Xiaojing Zhang and Ping Liang
    Citation: Cancer Imaging 2022 22:42
  35. The aim of this study is to propose a new TI-RADS and compare it with the American College of Radiology (2017 ACR)-TI-RADS and the 2020 Chinese (2020 C)-TI-RADS.

    Authors: Zhiguang Chen, Yue Du, Linggang Cheng, Yukang Zhang, Shuai Zheng, Rui Li, Wenkai Zhang, Wei Zhang and Wen He
    Citation: Cancer Imaging 2022 22:41
  36. To evaluate the parameters derived from arterial spin labeling (ASL) and multi-b-value diffusion-weighted imaging (DWI) for differentiating retropharyngeal lymph nodes (RLNs) in patients with nasopharyngeal ca...

    Authors: Xiaoduo Yu, Fan Yang, Xue Liu, Yanfeng Zhao, Yujie Li, Meng Lin, Lizhi Xie and Yuqing Shang
    Citation: Cancer Imaging 2022 22:40
  37. Current radiological assessments of 18fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging data in diffuse large B-cell lymphoma (DLBCL) can be time consuming, do not yield real-time information rega...

    Authors: S. Jemaa, J. N. Paulson, M. Hutchings, L. Kostakoglu, J. Trotman, S. Tracy, A. de Crespigny, R. A. D. Carano, T. C. El-Galaly, T. G. Nielsen and T. Bengtsson
    Citation: Cancer Imaging 2022 22:39
  38. Arterial enhancement fraction (AEF), derived from triphasic CT scans, is considered to indirectly reflect the ratio of hepatic arterial perfusion to total perfusion. The purpose of this study was to retrospect...

    Authors: Bin Chai, Dongqiao Xiang, Wei Wang, Yanqiao Ren, Fuquan Wang, Jihua Wang, Guofeng Zhou and Chuansheng Zheng
    Citation: Cancer Imaging 2022 22:38
  39. To evaluate effectivity of a 3D-motion correction algorithm in C-Arm CTs (CACT) with limited image quality (IQ) during transarterial chemoembolization (TACE).

    Authors: Lena S. Becker, Cornelia L. A. Dewald, Christian von Falck, Thomas Werncke, Sabine K. Maschke, Roman Kloeckner, Frank K. Wacker, Bernhard C. Meyer and Jan B. Hinrichs
    Citation: Cancer Imaging 2022 22:37
  40. We aimed to assess the clinical value of 18F-PSMA-1007 and 68Ga-PSMA-11 PET/MRI in the gross tumor volume (GTV) delineation of radiotherapy for prostate cancer (PCa).

    Authors: Yan-Nan Zhang, Zhen-Guo Lu, Shuai-Dong Wang, Xin Lu, Lei-Lei Zhu, Xu Yang, Li-Ping Fu, Jun Zhao, Hai-Feng Wang and Zuo-Lin Xiang
    Citation: Cancer Imaging 2022 22:36
  41. To investigate the magnetic resonance imaging (MRI)-based radiomics value in predicting the survival of patients with locally advanced cervical squamous cell cancer (LACSC) treated with concurrent chemoradioth...

    Authors: Xiaomiao Zhang, Jingwei Zhao, Qi Zhang, Sicong Wang, Jieying Zhang, Jusheng An, Lizhi Xie, Xiaoduo Yu and Xinming Zhao
    Citation: Cancer Imaging 2022 22:35
  42. To evaluate the anatomic site(s) of initial disease progression in patients with castration resistant metastatic prostate cancer (mCRPC) in the presence or absence of pre-treatment visceral metastases while on...

    Authors: Kathleen Ruchalski, Hyun J. Kim, Michael Douek, Steven Raman, Maitraya Patel, Victor Sai, Antonio Gutierrez, Benjamin Levine, Cheryce Fischer, Martin Allen-Auerbach, Pawan Gupta, Heidi Coy, Bianca Villegas, Matthew Brown and Jonathan Goldin
    Citation: Cancer Imaging 2022 22:34

Official journal of

Annual Journal Metrics

  • 2022 Citation Impact
    4.9 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.636 - SNIP (Source Normalized Impact per Paper)
    1.231 - SJR (SCImago Journal Rank)

    2023 Speed
    13 days submission to first editorial decision for all manuscripts (Median)
    123 days submission to accept (Median)

    2023 Usage 
    349 Altmetric mentions 

Download journal leaflet